TrialDiabetes care2010

Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control.

Maria Anita Radtke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.